What move does the options market price into Cullinan Therapeutics's report?

Implied ±38.6%, either direction.

How often does Cullinan Therapeutics move more than the options market prices?

0 of the last 8 reports moved at least as far as the implied move.

CGEMNasdaqBiological Products, (No Diagnostic Substances)

Cullinan Therapeutics, Inc. (CGEM) earnings date, market-implied expected move, and options open interest by expiry

11.30

+0.50 · +4.65%

post 11.30 −0.03%

After hours16:00 ETdelayed

Open11.50Volume1.8MMkt cap$695.0M

Day10.87 – 11.6654%52-wk6.73 – 23.1928%

CGEM

Cullinan Therapeutics, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±38.6%implied · straddle

6.7515.25

spot 11.00exp Nov 20ATM strike 11ATM straddle 5.00IV 291%

Nov 6 close

Expected move

Inputs

News

2dCullinan Therapeutics reports CLN-049 Phase 1 CRc 26% at 12 µg/kg (5/19)

News

Next report

Last report

+1.93%

vs ±23.3% implied · ×0.08

shaded = implied · ▲▼ = realized

Aug 6 '26 · confirmed

Implied vs realized

Largest filed tie

—

Supply chain

13F top-10 QoQ

+18.24%

shares held · 10 largest managers

13F · Jun 30 '26129d lag

184 managers

Top fund weight

0.40%

CGEM weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Cullinan Therapeutics (CGEM) is expected to report on Nov 12 before open (estimated date).

Implied vs realized

8 reports

0 of 8≥ implied

avg implied: ±22.4%
avg realized: ±2.8%

Feb 27 '25Feb 27 '25confirmed±11.2%▲+1.89%×0.17

May 8 '25May 8 '25confirmed±6.7%▲+0.91%×0.14

Aug 7 '25Aug 7 '25confirmed±56.2%▼−10.79%×0.19

Q3 FY25Nov 6 '25confirmed±13.0%▲+0.55%×0.04

Jan 8 '26Jan 8 '26confirmed±15.3%▲+1.83%×0.12

Q1 FY26Mar 10 '26confirmed±25.3%▼−2.61%×0.10

May 7 '26May 7 '26confirmed±28.5%▼−1.80%×0.06

Q2 FY26Aug 6 '26confirmed±23.3%▲+1.93%×0.08

quarterimplied−60%0+60%realized×

Q2 FY26±23.3%▲+1.93%×0.08

May '26±28.5%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 5 expiries · Nov 4 close

13.00OI · 5 expiries · Nov 4 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

2,431+10%Nov 2014d187+11%

1,500+6%Dec 1842d1.051,4220%1.05

743+26%Jan 1570d0.322,3380%0.32

381−1%Mar 19133d0.50756+2%0.50

408+4%Apr 16161d1.70240+1%1.70

ExpiryPutsCallsP/C

Nov 2014d2,431+10%187+11%13.00

Dec 1842d1,500+6%1,4220%1.05

Jan 1570d743+26%2,3380%0.32

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±38.6%

Funds 4

XBI±0.2%

IWM±0.0%

UWM±0.0%

VTI±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

No filed income statement.

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 6 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

FOMC ×1.18· ±3.7% vs ±3.1% · 24 releases

eventrelease day|move|up · n×base

FOMCrate decision±3.7%11 of 24×1.18

CPIconsumer prices±3.5%3 of 11×1.12

CPROFcorporate profits±3.4%6 of 12×1.07

GDPgross domestic product±2.9%9 of 20×0.94

NFPjobs report±2.8%3 of 10×0.90

PCEpersonal income & outlays±2.2%8 of 20×0.71

PPIproducer prices±1.8%9 of 11×0.58

Bar = avg |move| to ±4% · tick = ±3.1% avg day · ×base = |move| ÷ ±3.1% · min 6 releases

Earnings history

EPS -8.91 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 6 '26 · confirmed	-8.91	—
Q1 FY26	Mar 10 '26 · confirmed	-8.27	—
Q3 FY25	Nov 6 '25 · confirmed	-8.49	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod